Amphastar Pharmaceuticals Inc. Revenue 2012–2025
Amphastar Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2012 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Amphastar Pharmaceuticals Inc. revenue for the quarter ending March 31, 2026 was 171.2 M, a 0.38% increase year-over-year.
- Amphastar Pharmaceuticals Inc. revenue for the twelve months ending March 31, 2026 was 708.0 M, a 2.49% decrease year-over-year.
- Amphastar Pharmaceuticals Inc. annual revenue for 2025 was 719.9 M, a 1.65% decrease from 2024.
- Amphastar Pharmaceuticals Inc. annual revenue for 2024 was 732.0 M, a 13.59% increase from 2023.
- Amphastar Pharmaceuticals Inc. annual revenue for 2023 was 644.4 M, a 29.14% increase from 2022.
- Amphastar Pharmaceuticals Inc. annual revenue for 2022 was 499.0 M.
Amphastar Pharmaceuticals Inc. (AMPH) — Frequently Asked Questions
Amphastar Pharmaceuticals Inc. (AMPH) is a publicly traded US company. It has a market capitalization of $978M. In fiscal 2025 it reported revenue of $720M and net income of $98M. Explore AMPH's stock price, financial statements, earnings history, margins and key ratios below.
What is Amphastar Pharmaceuticals Inc.'s market cap?
Amphastar Pharmaceuticals Inc. (AMPH) has a market capitalization of $978M.
What is the AMPH stock price?
AMPH trades at $20.29 (+0.64% on the day).
How much revenue does Amphastar Pharmaceuticals Inc. make?
Amphastar Pharmaceuticals Inc. reported revenue of $720M in fiscal 2025.
Is AMPH profitable?
In fiscal 2025, Amphastar Pharmaceuticals Inc. reported net income of $98M.